Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey Liu

Showing results (401-410 of 574) with videos related to

Pageof 58
Sort By:
Clinical Colorectal Cancer|November 13, 2017
Molecular Profiling of Patients With Advanced Colorectal Cancer: Princess Margaret Cancer Centre ExperienceJoanne W Chiu, Monika K Krzyzanowska, Stefano Serra, et al.
JAMA Oncology|December 9, 2016
Effect of Standard Radiotherapy With Cisplatin vs Accelerated Radiotherapy With Panitumumab in Locoregionally Advanced Squamous Cell Head and Neck Carcinoma: A Randomized Clinical TrialLillian L Siu, John N Waldron, Bingshu E Chen, et al.
JCO Clinical Cancer Informatics|September 25, 2025
Development of Machine Learning Systems to Predict Cancer-Related Symptoms With Validation Across a Health Care SystemBaijiang Yuan, Muammar Kabir, Jiang Chen He, et al.
Therapeutic Advances in Medical Oncology|September 26, 2022
Plasma-first: accelerating lung cancer diagnosis and molecular profiling through liquid biopsyMiguel Garcia-Pardo, Kasia Czarnecka, Jennifer H Law, et al.
The Lancet. Oncology|March 15, 2016
Activity and safety of ceritinib in patients with ALK-rearranged non-small-cell lung cancer (ASCEND-1): updated results from the multicentre, open-label, phase 1 trialDong-Wan Kim, Ranee Mehra, Daniel S W Tan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2016
Fc-γ Receptor Polymorphisms, Cetuximab Therapy, and Survival in the NCIC CTG CO.17 Trial of Colorectal CancerGeoffrey Liu, Dongsheng Tu, Marcia Lewis, et al.
Science Translational Medicine|November 17, 2021
Assessing therapy response in patient-derived xenograftsJanosch Ortmann, Ladislav Rampášek, Elijah Tai, et al.
Lung Cancer (Amsterdam, Netherlands)|May 25, 2020
EGFR-mutated lung adenocarcinomas from patients who progressed on EGFR-inhibitors show high engraftment rates in xenograft modelsSebastiao N Martins-Filho, Jessica Weiss, Nhu-An Pham, et al.
Genes|May 15, 2019
Outcome Definition Influences the Relationship Between Genetic Polymorphisms of <i>ERCC1</i>, <i>ERCC2</i>, <i>SLC22A2</i> and Cisplatin Nephrotoxicity in Adult Testicular Cancer PatientsZulfan Zazuli, Leila S Otten, Britt I Drögemöller, et al.
Pharmacoepidemiology and Drug Safety|April 28, 2026
Identifying the Initiation of a New Line of Therapy for Metastatic Lung, Breast, and Colorectal Cancer in Real-World Data: A Scoping ReviewOluwadamilola Onasanya, Seyed Hamidreza Mahmoudpour, Benjamin Bates, et al.
Pageof 58

Showing results (401-410 of 574) with videos related to

Sort By:
Pageof 58
Clinical Colorectal Cancer|November 13, 2017
Molecular Profiling of Patients With Advanced Colorectal Cancer: Princess Margaret Cancer Centre ExperienceJoanne W Chiu, Monika K Krzyzanowska, Stefano Serra, et al.
JAMA Oncology|December 9, 2016
Effect of Standard Radiotherapy With Cisplatin vs Accelerated Radiotherapy With Panitumumab in Locoregionally Advanced Squamous Cell Head and Neck Carcinoma: A Randomized Clinical TrialLillian L Siu, John N Waldron, Bingshu E Chen, et al.
JCO Clinical Cancer Informatics|September 25, 2025
Development of Machine Learning Systems to Predict Cancer-Related Symptoms With Validation Across a Health Care SystemBaijiang Yuan, Muammar Kabir, Jiang Chen He, et al.
Therapeutic Advances in Medical Oncology|September 26, 2022
Plasma-first: accelerating lung cancer diagnosis and molecular profiling through liquid biopsyMiguel Garcia-Pardo, Kasia Czarnecka, Jennifer H Law, et al.
The Lancet. Oncology|March 15, 2016
Activity and safety of ceritinib in patients with ALK-rearranged non-small-cell lung cancer (ASCEND-1): updated results from the multicentre, open-label, phase 1 trialDong-Wan Kim, Ranee Mehra, Daniel S W Tan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2016
Fc-γ Receptor Polymorphisms, Cetuximab Therapy, and Survival in the NCIC CTG CO.17 Trial of Colorectal CancerGeoffrey Liu, Dongsheng Tu, Marcia Lewis, et al.
Science Translational Medicine|November 17, 2021
Assessing therapy response in patient-derived xenograftsJanosch Ortmann, Ladislav Rampášek, Elijah Tai, et al.
Lung Cancer (Amsterdam, Netherlands)|May 25, 2020
EGFR-mutated lung adenocarcinomas from patients who progressed on EGFR-inhibitors show high engraftment rates in xenograft modelsSebastiao N Martins-Filho, Jessica Weiss, Nhu-An Pham, et al.
Genes|May 15, 2019
Outcome Definition Influences the Relationship Between Genetic Polymorphisms of <i>ERCC1</i>, <i>ERCC2</i>, <i>SLC22A2</i> and Cisplatin Nephrotoxicity in Adult Testicular Cancer PatientsZulfan Zazuli, Leila S Otten, Britt I Drögemöller, et al.
Pharmacoepidemiology and Drug Safety|April 28, 2026
Identifying the Initiation of a New Line of Therapy for Metastatic Lung, Breast, and Colorectal Cancer in Real-World Data: A Scoping ReviewOluwadamilola Onasanya, Seyed Hamidreza Mahmoudpour, Benjamin Bates, et al.
Pageof 58